DPP-4-IN-13

DPP-4-IN-13

• UNSPSC Description: DPP-4-IN-13 (compound 9i) is a competitive DPP4 inhibitor with the IC50 of 9.25 μM and can be used for study of type 2 diabetes[1].
• Target Antigen: Dipeptidyl Peptidase
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Metabolism-protein/nucleotide metabolism
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/dpp-4-in-13.html
• Smiles: BrC1=CC2=C(N=C(CN3C(N(C)C(C=C3N4CCC(N)CC4)=O)=O)N(C5=CC=C(Cl)C=C5)C2=O)C=C1
• Molecular Weight: 571.85
• References & Citations: [1]Baziar L, et al. Design, synthesis, biological evaluation and computational studies of 4-Aminopiperidine-3, 4-dihyroquinazoline-2-uracil derivatives as promising antidiabetic agents. Sci Rep. 2024;14(1):26538.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported